PlainPharmaWatch

CMS Open Payments · Program Year 2024

Evoke Pharma, Inc.

Evoke Pharma, Inc. reported $292,784.51 in payments to 3,417 physicians and teaching hospitals across 3,417 transactions.

See the rankings → How this is sourced
$292.8K
Total payments
3,417
Transactions
3,417
Recipients
−$185.4K
General Payments vs PY2023

Evoke Pharma, Inc. reported $292,784.51 in payments to 3,417 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #897 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $85.68 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Evoke Pharma, Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#897
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Evoke Pharma, Inc.'s CMS-reported General Payments decreased by $185.4K (−38.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: EVOKE PHARMA, INC.PY2023: EVOKE PHARMA, INC.PY2024: EVOKE PHARMA, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$478.2KPY2024$292.8K
PY2023
$478,214.55
PY2024
$292,784.51

How Evoke Pharma, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Evoke Pharma, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$292,785 Top 47% higher than 53% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Evoke Pharma, Inc.

In Program Year 2024, Evoke Pharma, Inc. reported $292,784.51 in payments to 3,417 physicians and teaching hospitals across 3,417 individual transactions, an average of $85.68 per transaction and $85.68 per recipient. That total places Evoke Pharma, Inc. at rank #897 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 5-category general-payment breakdown below at $168.5K (57.5% of the company's reported total, 74 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 5 types of general payments, Evoke Pharma, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $168.5K - 57.5% of the company's reported total.

How Evoke Pharma, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$168.5K2. Food and Beverage$84.0K3. Travel and Lodging$36.4K4. Honoraria$2.5K5. Consulting Fee$1.4K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $168.5K 74
Food and Beverage $84.0K 3,275
Travel and Lodging $36.4K 55
Honoraria $2.5K 12
Consulting Fee $1.4K 1

Recipient Concentration in General Payments

The five largest recipient relationships account for $107,887.83 (36.8%) of $292,784.51 in this company's General Payments records across 1,983 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Evoke Pharma, Inc.

The five named recipients with the highest reported General Payments from this company

Jignesh Shah$31.0KSusan Tracy Wolgamott$24.1KDaksesh Bipin Patel$19.1KAbdelhai Abdelqader$16.9KFred Fowler$16.8K
  1. 1

    Jignesh Shah

    $31,000.42 across 32 reported transactions

  2. 2

    Susan Tracy Wolgamott

    $24,096.81 across 31 reported transactions

  3. 3

    Daksesh Bipin Patel

    $19,083.79 across 25 reported transactions

  4. 4

    Abdelhai Abdelqader

    $16,866.81 across 14 reported transactions

  5. 5

    Fred Fowler

    $16,840.00 across 20 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $85.68. Average per recipient: $85.68.

Total Amount

$292,784.51

Avg per Transaction

$85.68

Avg per Recipient

$85.68

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Evoke Pharma, Inc. Share

0.0%

#897 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Evoke Pharma, Inc.

Nexxt Spine LLC

$292.8K 358 recipients

Exo Imaging, Inc.

$292.7K 175 recipients

Verity Pharmaceuticals Inc.

$293.4K 4,640 recipients

IlluminOss Medical, Inc.

$293.7K 469 recipients

Intra-Sana Laboratories

$291.3K 3,142 recipients

Merck KGaA

$290.6K 101 recipients

Frequently Asked Questions

How much did Evoke Pharma, Inc. pay to physicians and hospitals in 2024? ▾
Evoke Pharma, Inc. made $292,784.51 in payments to physicians and hospitals in Program Year 2024, across 3,417 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Evoke Pharma, Inc.? ▾
Evoke Pharma, Inc. made payments to 3,417 physicians and teaching hospitals in 2024. The average payment per recipient was $85.68.
What types of payments did Evoke Pharma, Inc. make? ▾
5 categories of general payment make up Evoke Pharma, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $168.5K, representing 57.5% of the company's reported total.
How does Evoke Pharma, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Evoke Pharma, Inc. sits at #897 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Evoke Pharma, Inc.? ▾
In 2024, Evoke Pharma, Inc. averaged $85.68 per transaction across 3,417 transactions to 3,417 recipients.
Where does the payment data for Evoke Pharma, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Evoke Pharma, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.